The effect of iron therapy on oxidative stress and intestinal microbiota in inflammatory bowel diseases: A review on the conundrum
One in five patients with Inflammatory Bowel Disease (IBD) suffers from anemia, most frequently caused by iron deficiency. Anemia and iron deficiency are associated with worse disease outcomes, reduced quality of life, decreased economic participation, and increased healthcare costs. International g...
Main Authors: | R. Loveikyte, A.R. Bourgonje, H. van Goor, G. Dijkstra, A.E. van der Meulen – de Jong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Redox Biology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231723003518 |
Similar Items
-
Sucrosomial Iron Supplementation for the Treatment of Iron Deficiency Anemia in Inflammatory Bowel Disease Patients Refractory to Oral Iron Treatment
by: Guillermo Bastida, et al.
Published: (2021-05-01) -
Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?
by: Tamás Resál, et al.
Published: (2021-07-01) -
Anemia and Iron Deficiency in Outpatients with Inflammatory Bowel Disease: Ubiquitous Yet Suboptimally Managed
by: Roberta Loveikyte, et al.
Published: (2022-11-01) -
Iron Therapy in Inflammatory Bowel Disease
by: Aditi Kumar, et al.
Published: (2020-11-01) -
Iron Supplementation at the Crossroads of Nutrition and Gut Microbiota: The State of the Art
by: Ana M. Puga, et al.
Published: (2022-05-01)